Evogene Reports Fourth Quarter and Full Year 2015 Financial Results

Go back to Evogene Reports Fourth Quarter and Full Year 2015 Financial Results

Evogene (EVGN) Misses Q4 EPS by 5c

March 1, 2016 7:09 AM EST

Evogene (NYSE: EVGN) reported Q4 EPS of ($0.22), $0.05 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.46 million versus the consensus estimate of $3.9 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

... More